Works matching AU Sang-Hee Cho

Results: 113
    1

    The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.

    Published in:
    2009
    By:
    • Deok-Hwan Yang;
    • Jung-Joon Min;
    • Yong Jeong;
    • Jae-Sook Ahn;
    • Yeo-Kyeoung Kim;
    • Sang-Hee Cho;
    • Ik-Joo Chung;
    • Hee-Seung Bom;
    • Hyeoung-Joon Kim;
    • Je-Jung Lee;
    • Yang, Deok-Hwan;
    • Min, Jung-Joon;
    • Jeong, Yong Yeon;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo;
    • Bom, Hee-Seung;
    • Kim, Hyeoung-Joon;
    • Lee, Je-Jung
    Publication type:
    journal article
    2
    3
    4
    5
    6

    Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2014, v. 26, n. 4, p. 248, doi. 10.1179/1973947813Y.0000000146
    By:
    • Cho, Eun Ae;
    • Choi, Won-Young;
    • Kim, Seung-Hun;
    • Hong, Ji-Yun;
    • Jung, Sung-Hoon;
    • Kim, Min-Jee;
    • Hwang, Jun-Eul;
    • Bae, Woo-Kyun;
    • Shim, Hyun-Jeong;
    • Lee, Kyung-Hwa;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    14

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Valence Change of Mn Ions in BaTiO.

    Published in:
    Journal of the American Ceramic Society, 1995, v. 78, n. 10, p. 2845, doi. 10.1111/j.1151-2916.1995.tb08065.x
    By:
    • Lee, Joon-Hyung;
    • Kim, Sung-Hee;
    • Cho, Sang-Hee
    Publication type:
    Article
    35
    36
    37
    38
    39

    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
    By:
    • Satoru Iwasa;
    • Kei Muro;
    • Satoshi Morita;
    • Young Suk Park;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Tomohiro Nishina;
    • Hiroshi Matsuoka;
    • Joong Bae Ahn;
    • Keun-Wook Lee;
    • Yong Sang Hong;
    • Sae Won Han;
    • Sang-Hee Cho;
    • Dong-Sheng Zhang;
    • Wei-Jia Fang;
    • Li Bai;
    • Xiang-Lin Yuan;
    • Ying Yuan;
    • Yasuhide Yamada;
    • Junichi Sakamoto
    Publication type:
    Article
    40

    Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.

    Published in:
    Cancer Science, 2020, v. 111, n. 9, p. 3268, doi. 10.1111/cas.14526
    By:
    • Hong, Chang‐Soo;
    • Sun, Eun‐Gene;
    • Choi, Ji‐Na;
    • Kim, Dae‐Hwan;
    • Kim, Jo‐Heon;
    • Ryu, Kyung‐Hyun;
    • Shim, Hyun‐Jeong;
    • Hwang, Jun‐Eul;
    • Bae, Woo‐Kyun;
    • Kim, Hyeong‐Rok;
    • Kim, Kyung Keun;
    • Jung, Chaeyong;
    • Chung, Ik‐Joo;
    • Cho, Sang‐Hee
    Publication type:
    Article
    41
    42
    43

    A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 665, doi. 10.1007/s00280-012-1956-1
    By:
    • Choi, Yoon;
    • Oh, Sang;
    • Kim, Jun;
    • Nam, Seung-Hyun;
    • Kim, Bong-Seog;
    • Cho, Sang-Hee;
    • Chung, Ik;
    • Song, Eun-Kee;
    • Yim, Chang-Yeol;
    • Baek, Jin;
    • Jeung, Hei-Cheul;
    • Hong, Young;
    • Yang, Sung;
    • Kang, Hye
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50